Mark Cuban Cost Plus Drug Company Collaborates with Morris & Dickson for Medication Access
Mark Cuban Cost Plus Drug Company partners with Morris & Dickson to enhance access to essential injectable medications. 💊🤝
April 17, 2025
Follow us
latest articles
Discover the newest research about AI innovations in Research.
Subacute Sclerosing Panencephalitis: Recent Advances in Pathogenesis, Diagnosis, and Treatment.
Subacute Sclerosing Panencephalitis: SSPE’s global incidence, pathogenesis, and treatment options. 🧠📉
April 17, 2025
ABHI Announces 21 UK HealthTech Companies for US Accelerator Program
ABHI selects 21 UK HealthTech companies for US accelerator program, enhancing access to the US healthcare market. 🇺🇸💼
April 16, 2025
Transforming Nursing Education: Harnessing the Power of Immersive Technologies and Artificial Intelligence to Promote Self-care and Enhance Learning.
Exploring immersive tech & AI in nursing education: Enhancing self-care & learning outcomes. 📚🤖
April 16, 2025
Complex Anatomy, Advanced Techniques: Microsurgical Clipping of a Ruptured Hypophyseal Artery Aneurysm.
Microsurgical clipping of a ruptured hypophyseal artery aneurysm shows promising outcomes in complex cases. 🧠🔍 Precision techniques are vital!
April 15, 2025
Endodontic education – present status and future directions.
Endodontic education evolves with AI, AR/VR, and innovative typodonts, enhancing skills and self-efficacy in learners. 📚🔍
April 15, 2025
Toward an Automatic Classification of the Different Stages of Sleep: Exploring Patterns of Neural Activity in the Subthalamic Nucleus.
Exploring subthalamic nucleus activity reveals 94% accuracy in classifying sleep stages, aiding sleep disorder therapies. 🧠💤
April 15, 2025
Digital transformation in healthcare management: from Artificial Intelligence to blockchain.
Digital transformation in healthcare enhances efficiency, patient outcomes, and data security through AI, blockchain, and IoT integration. 📈💻
April 14, 2025
Novel first-trimester serum biomarkers for early prediction of gestational diabetes mellitus.
Novel biomarkers predict gestational diabetes in IVF: AUC 0.906, sensitivity 75%, specificity 94.7%. Key findings from PubMed article. 📊🤰
April 14, 2025
Novel endometrial receptivity test increases clinical pregnancy and live birth rates in patients with recurrent implantation failure: Secondary analysis of a prospective clinical trial.
Endometrial receptivity testing boosts clinical pregnancy rates by 22.78% in recurrent implantation failure cases. 📈👶
April 14, 2025